Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition

J. Ćmielová, R. Havelek, J. Vávrová, M. Řezáčová,

. 2015 ; 32 (5) : 138. [pub] 20150324

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010421
E-zdroje Online Plný text

NLK ProQuest Central od 1997-03-01 do 2017-12-31
Medline Complete (EBSCOhost) od 2013-03-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-03-01 do 2017-12-31

The aim of the present study is to evaluate the role of ATM (KU55933) and DNA-PK (NU7441) inhibitors in the repair of double-strand breaks and downstream signaling of DNA damage introduced by ionizing radiation. The irradiation of MCF-7 cells alone increased the proportion of cells in the G1 phase in comparison with mock-treated cells. After ATM inhibitor pretreatment, the cells were more accumulated in the G2 phase, whereas DNA-PK inhibitor application increased the percentage of cells in the G1 phase. ATM and DNA-PK inhibitor application alone increased the sensitivity of MCF-7 cells to ionizing radiation; however, combining both inhibitors together resulted in a further enhancement of cell death. Unexpectedly, combining both inhibitors decreased the percentage of senescent cells and increased G2 cell cycle arrest 3 days after treatment. After irradiation, the p21 protein was increased and Chk1 and Chk2 were activated. These proteins were not increased in cells pretreated with the ATM inhibitor prior to ionizing radiation exposure, albeit DNA-PK inhibitor application did not affect the amount of proteins detected. Formation of γH2AX was found to be ATM and DNA-PK dependent, application of the ATM inhibitor suppressed incidence of γH2AX, whereas DNA-PK caused persistence of γH2AX. Our results suggest that the further investigation of the ATM inhibitor in combination with the DNA-PK inhibitor as sensitizers preventing cell senescence and promoting cell death in breast carcinoma MCF-7 cells is warranted.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010421
003      
CZ-PrNML
005      
20160415111256.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12032-015-0591-1 $2 doi
024    7_
$a 10.1007/s12032-015-0591-1 $2 doi
035    __
$a (PubMed)25801233
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ćmielová, Jana $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Simkova 870, 500 38, Hradec Kralove, Czech Republic.
245    10
$a Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition / $c J. Ćmielová, R. Havelek, J. Vávrová, M. Řezáčová,
520    9_
$a The aim of the present study is to evaluate the role of ATM (KU55933) and DNA-PK (NU7441) inhibitors in the repair of double-strand breaks and downstream signaling of DNA damage introduced by ionizing radiation. The irradiation of MCF-7 cells alone increased the proportion of cells in the G1 phase in comparison with mock-treated cells. After ATM inhibitor pretreatment, the cells were more accumulated in the G2 phase, whereas DNA-PK inhibitor application increased the percentage of cells in the G1 phase. ATM and DNA-PK inhibitor application alone increased the sensitivity of MCF-7 cells to ionizing radiation; however, combining both inhibitors together resulted in a further enhancement of cell death. Unexpectedly, combining both inhibitors decreased the percentage of senescent cells and increased G2 cell cycle arrest 3 days after treatment. After irradiation, the p21 protein was increased and Chk1 and Chk2 were activated. These proteins were not increased in cells pretreated with the ATM inhibitor prior to ionizing radiation exposure, albeit DNA-PK inhibitor application did not affect the amount of proteins detected. Formation of γH2AX was found to be ATM and DNA-PK dependent, application of the ATM inhibitor suppressed incidence of γH2AX, whereas DNA-PK caused persistence of γH2AX. Our results suggest that the further investigation of the ATM inhibitor in combination with the DNA-PK inhibitor as sensitizers preventing cell senescence and promoting cell death in breast carcinoma MCF-7 cells is warranted.
650    _2
$a protokoly protinádorové kombinované chemoterapie $x farmakologie $7 D000971
650    _2
$a ATM protein $x antagonisté a inhibitory $x metabolismus $7 D064007
650    _2
$a kontrolní body buněčného cyklu $x účinky léků $7 D059447
650    _2
$a buněčná smrt $x účinky léků $7 D016923
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a checkpoint kinasa 2 $x metabolismus $7 D064447
650    _2
$a chromony $x farmakologie $7 D002867
650    _2
$a inhibitor p21 cyklin-dependentní kinasy $x metabolismus $7 D050759
650    _2
$a poškození DNA $x účinky léků $7 D004249
650    _2
$a oprava DNA $x účinky léků $7 D004260
650    _2
$a proteinkinasa aktivovaná DNA $x antagonisté a inhibitory $x metabolismus $7 D051747
650    _2
$a DNA vazebné proteiny $x antagonisté a inhibitory $7 D004268
650    _2
$a G1 fáze $x účinky léků $7 D016193
650    _2
$a G2 fáze $x účinky léků $7 D016195
650    _2
$a histony $7 D006657
650    _2
$a lidé $7 D006801
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a morfoliny $x farmakologie $7 D009025
650    _2
$a proteinkinasy $x metabolismus $7 D011494
650    _2
$a pyrony $x farmakologie $7 D011753
650    _2
$a ionizující záření $7 D011839
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Havelek, Radim
700    1_
$a Vávrová, Jiřina
700    1_
$a Řezáčová, Martina
773    0_
$w MED00012126 $t Medical oncology (Northwood, London, England) $x 1559-131X $g Roč. 32, č. 5 (2015), s. 138
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25801233 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160415111341 $b ABA008
999    __
$a ok $b bmc $g 1113850 $s 934789
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 32 $c 5 $d 138 $e 20150324 $i 1559-131X $m Medical oncology $n Med Oncol $x MED00012126
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...